HHV-6A, HHV-6B, and HHV-7 in Encephalitis

Joseph Ongrádi, Balázs Stercz, Tetsushi Yoshikawa, Dharam V. Ablashi

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Among etiological agents of sporadic viral encephalitis, human herpesvirus (HHV)-6A, HHV-6B, and HHV-7 have been identified. In immunocompetent individuals, exanthema subitum rarely associates with encephalitis and sequelae, whereas HHV-7 might induce serious encephalitis with generalized symptoms. Risk factors for reactivation of HHV-6 and HHV-7 and encephalitis are unrelated cord blood cell transplantation, repeated hematopoietic stem cell transplantation, young age, immunsuppressive and cytotoxic drugs, and chromosomally integrated HHV-6. The most severe manifestation is the syndrome of posttransplantation acute limbic encephalitis (PALE), which is associated with high morbidity. Posterior reversible encephalopathy syndrome (PRES) is associated with medical interventions in underlying disorders. HHV-6 enters the brain via the olfactory route, spreads to the brain stem, hippocampus, limbic tissue, and cerebrospinal fluid (CSF). Proinflammatory cytokines mediate inflammation. Early and serial quantitation of HHV-6A, HHV-6B, and HHV-7 in CSF is used to monitor disease course. Ganciclovir, valganciclovir, foscarnet therapy, and preemptive therapy can eliminate viruses in the majority of cases.

Original languageEnglish
Title of host publicationHuman Herpesviruses HHV-6A, HHV-6B, and HHV-7, Third Edition
PublisherElsevier B.V.
Pages81-98
Number of pages18
ISBN (Print)9780444627032
DOIs
Publication statusPublished - 01-01-2014

Fingerprint

Human Herpesvirus 7
Human Herpesvirus 6
Encephalitis
Cerebrospinal Fluid
Exanthema Subitum
Limbic Encephalitis
Posterior Leukoencephalopathy Syndrome
Viral Encephalitis
Foscarnet
Ganciclovir
Hematopoietic Stem Cell Transplantation
Cell Transplantation
Fetal Blood
Brain Stem
Hippocampus
Blood Cells
Cytokines
Viruses
Inflammation
Morbidity

All Science Journal Classification (ASJC) codes

  • Immunology and Microbiology(all)

Cite this

Ongrádi, J., Stercz, B., Yoshikawa, T., & Ablashi, D. V. (2014). HHV-6A, HHV-6B, and HHV-7 in Encephalitis. In Human Herpesviruses HHV-6A, HHV-6B, and HHV-7, Third Edition (pp. 81-98). Elsevier B.V.. https://doi.org/10.1016/B978-0-444-62703-2.00005-7
Ongrádi, Joseph ; Stercz, Balázs ; Yoshikawa, Tetsushi ; Ablashi, Dharam V. / HHV-6A, HHV-6B, and HHV-7 in Encephalitis. Human Herpesviruses HHV-6A, HHV-6B, and HHV-7, Third Edition. Elsevier B.V., 2014. pp. 81-98
@inbook{2a27766c4d8d4363b2426a5f9ae2594e,
title = "HHV-6A, HHV-6B, and HHV-7 in Encephalitis",
abstract = "Among etiological agents of sporadic viral encephalitis, human herpesvirus (HHV)-6A, HHV-6B, and HHV-7 have been identified. In immunocompetent individuals, exanthema subitum rarely associates with encephalitis and sequelae, whereas HHV-7 might induce serious encephalitis with generalized symptoms. Risk factors for reactivation of HHV-6 and HHV-7 and encephalitis are unrelated cord blood cell transplantation, repeated hematopoietic stem cell transplantation, young age, immunsuppressive and cytotoxic drugs, and chromosomally integrated HHV-6. The most severe manifestation is the syndrome of posttransplantation acute limbic encephalitis (PALE), which is associated with high morbidity. Posterior reversible encephalopathy syndrome (PRES) is associated with medical interventions in underlying disorders. HHV-6 enters the brain via the olfactory route, spreads to the brain stem, hippocampus, limbic tissue, and cerebrospinal fluid (CSF). Proinflammatory cytokines mediate inflammation. Early and serial quantitation of HHV-6A, HHV-6B, and HHV-7 in CSF is used to monitor disease course. Ganciclovir, valganciclovir, foscarnet therapy, and preemptive therapy can eliminate viruses in the majority of cases.",
author = "Joseph Ongr{\'a}di and Bal{\'a}zs Stercz and Tetsushi Yoshikawa and Ablashi, {Dharam V.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/B978-0-444-62703-2.00005-7",
language = "English",
isbn = "9780444627032",
pages = "81--98",
booktitle = "Human Herpesviruses HHV-6A, HHV-6B, and HHV-7, Third Edition",
publisher = "Elsevier B.V.",

}

Ongrádi, J, Stercz, B, Yoshikawa, T & Ablashi, DV 2014, HHV-6A, HHV-6B, and HHV-7 in Encephalitis. in Human Herpesviruses HHV-6A, HHV-6B, and HHV-7, Third Edition. Elsevier B.V., pp. 81-98. https://doi.org/10.1016/B978-0-444-62703-2.00005-7

HHV-6A, HHV-6B, and HHV-7 in Encephalitis. / Ongrádi, Joseph; Stercz, Balázs; Yoshikawa, Tetsushi; Ablashi, Dharam V.

Human Herpesviruses HHV-6A, HHV-6B, and HHV-7, Third Edition. Elsevier B.V., 2014. p. 81-98.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - HHV-6A, HHV-6B, and HHV-7 in Encephalitis

AU - Ongrádi, Joseph

AU - Stercz, Balázs

AU - Yoshikawa, Tetsushi

AU - Ablashi, Dharam V.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Among etiological agents of sporadic viral encephalitis, human herpesvirus (HHV)-6A, HHV-6B, and HHV-7 have been identified. In immunocompetent individuals, exanthema subitum rarely associates with encephalitis and sequelae, whereas HHV-7 might induce serious encephalitis with generalized symptoms. Risk factors for reactivation of HHV-6 and HHV-7 and encephalitis are unrelated cord blood cell transplantation, repeated hematopoietic stem cell transplantation, young age, immunsuppressive and cytotoxic drugs, and chromosomally integrated HHV-6. The most severe manifestation is the syndrome of posttransplantation acute limbic encephalitis (PALE), which is associated with high morbidity. Posterior reversible encephalopathy syndrome (PRES) is associated with medical interventions in underlying disorders. HHV-6 enters the brain via the olfactory route, spreads to the brain stem, hippocampus, limbic tissue, and cerebrospinal fluid (CSF). Proinflammatory cytokines mediate inflammation. Early and serial quantitation of HHV-6A, HHV-6B, and HHV-7 in CSF is used to monitor disease course. Ganciclovir, valganciclovir, foscarnet therapy, and preemptive therapy can eliminate viruses in the majority of cases.

AB - Among etiological agents of sporadic viral encephalitis, human herpesvirus (HHV)-6A, HHV-6B, and HHV-7 have been identified. In immunocompetent individuals, exanthema subitum rarely associates with encephalitis and sequelae, whereas HHV-7 might induce serious encephalitis with generalized symptoms. Risk factors for reactivation of HHV-6 and HHV-7 and encephalitis are unrelated cord blood cell transplantation, repeated hematopoietic stem cell transplantation, young age, immunsuppressive and cytotoxic drugs, and chromosomally integrated HHV-6. The most severe manifestation is the syndrome of posttransplantation acute limbic encephalitis (PALE), which is associated with high morbidity. Posterior reversible encephalopathy syndrome (PRES) is associated with medical interventions in underlying disorders. HHV-6 enters the brain via the olfactory route, spreads to the brain stem, hippocampus, limbic tissue, and cerebrospinal fluid (CSF). Proinflammatory cytokines mediate inflammation. Early and serial quantitation of HHV-6A, HHV-6B, and HHV-7 in CSF is used to monitor disease course. Ganciclovir, valganciclovir, foscarnet therapy, and preemptive therapy can eliminate viruses in the majority of cases.

UR - http://www.scopus.com/inward/record.url?scp=84903221235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903221235&partnerID=8YFLogxK

U2 - 10.1016/B978-0-444-62703-2.00005-7

DO - 10.1016/B978-0-444-62703-2.00005-7

M3 - Chapter

SN - 9780444627032

SP - 81

EP - 98

BT - Human Herpesviruses HHV-6A, HHV-6B, and HHV-7, Third Edition

PB - Elsevier B.V.

ER -

Ongrádi J, Stercz B, Yoshikawa T, Ablashi DV. HHV-6A, HHV-6B, and HHV-7 in Encephalitis. In Human Herpesviruses HHV-6A, HHV-6B, and HHV-7, Third Edition. Elsevier B.V. 2014. p. 81-98 https://doi.org/10.1016/B978-0-444-62703-2.00005-7